Bio Techne Corp (TECH) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bio techne Corp  (NASDAQ: TECH)


Bio Techne's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bio Techne's ROI in the fourth quarter of 2026?
Bio techne Corp achieved a return on average invested assets (ROI) of 7.87 % in its fourth quarter of 2026, which is below Bio Techne's average return on investment, which stands at 9.05%.

ROI has improved compared to 4.83% in the third quarter of 2026, due to net income growth.

Within the Healthcare sector 36 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2026 from 1190 to 1519.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Investment Change TTM -2.12 % -5.04 % -4.94 % -2.94 % -1.12 %
Y / Y Net Income Change TTM 147.77 % -16.79 % -25.65 % 5.12 % 80.84 %
Investment (TTM) in Millions 2,423 2,285 2,265 2,266 2,265
Return On Investment (TTM) 7.87 % 4.83 % 3.55 % 3.37 % 3.11 %
TECH's Overall Ranking # 1519 # 1190 # 1454 # 1404 # 1400
Seq. Investment Change TTM 1.74 % -0.69 % -1.33 % -1.83 % -1.29 %
Seq. Net Income Change TTM 65.99 % 35.09 % 4 % 6.25 % -44.25 %
Net Income (TTM) in Millions 182 110 81 78 73

TECH Company Profile >> Back to TECH Roi Comparisons >> See Annual TECH Return On Investment



Return On Investment TECH's Ranking
Within: No.
Industry # 5
Sector # 37
Overall # 1519

Return On Investment Statistics
High Average Low
15.71 %
9.05 %
3.01 %
(Jun 30 2013)   (Jun 30 2025)







Financial Statements
Bio Techne's IV. Quarter Investments $ 2,423 Millions TECH's Balance sheet
Bio Techne's IV. Quarter Income $ 55 Millions Quarterly TECH's Income Statement
TECH's Income by Division See TECH's Income by Division


TECH Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 2,423 2,265 2,388 2,317 2,118
Y / Y Investment Growth 6.99 % -5.15 % 3.08 % 9.37 % -0.04 %
Net Income in Millions 182 73 168 285 263
Y / Y Net Income Growth 147.77 % -56.34 % -41.11 % 8.49 % 88.49 %
Annual Return On Investment 7.51 % 3.24 % 7.04 % 12.32 % 12.42 %


Annual Roi Comment
In the fiscal year 2026 ROI improved to 7.51 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TECH's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TECH's Competitors
Subscribers only: Roi for Bio Techne's Suppliers
Subscribers only: Return On Investment for TECH's Customers

Other Ratios
TECH's Roa TECH's Inventory Turnover Ratio TECH's Growth Rates TECH's Dividend Statistics
TECH's Profitability Ratios TECH's Asset Turnover Ratio TECH's Dividend Growth
TECH's Roe TECH's Valuation Ratios TECH's Financial Strength Ratios TECH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %

Date modified: 2026-08-29T04:46:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.